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Abstract
Background: Sufficient information from in vitro and in vivo studies has become available to permit computer modeling of
the processes that occur in the myometrium during labor. This development allows the in silico investigation of pathological
mechanisms and the trialing of potential treatments.
Methods/Results: Based on the human literature, we developed a computer model of the immune-endocrine environment
of the myometrial cell. The interactions between molecules are represented by differential equations. The model is designed
to simulate the estrogen and progesterone receptor changes during pregnancy and particularly the changes in the
progesterone receptor (PR) isoforms A and B that are thought to mediate functional progesterone withdrawal in the human
at labor. Parturition is represented by an increase in the PRA to PRB ratio to levels seen in women in labor. Infection is shown
by inducing inflammation in the system by increasing phospho-IkB kinase concentration (IKK) levels; which lead to
increased NF-kB activation, causing an increase in the PRA/PRB ratio. We examined the effects of progesterone or cyclo-
oxygenase 2 (Cox2) inhibitor treatments on the PRA/PRB ratio in silico. The model predicted that high doses of progesterone
and Cox2 inhibition would be effective in preventing an NF-kB-induced PRA/PRB ratio increase to the levels found during
labor.
Conclusions: Our data illustrate the use of dynamic biological computer simulations to test the effectiveness of therapeutic
interventions. This may allow the early rejection of ineffective therapies prior to expensive field trials.
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Preterm delivery is a common complication of pregnancy,
occurring in approximately 12% of the pregnancies in the US and
the rates are increasing. Premature birth is associated with 70% of
neonatal mortality and 50% of cases of cerebral palsy [1]. About
45% (.$5 billion/year) of all infant health care expenditure in the
US is related to prematurity [1].
Although it is a syndrome rather than a single condition, in
.80% of the preterm deliveries ,32 weeks of gestation there is
intra-uterine infection that is subclinical where maternal and fetal
inflammatory response-induced cyclo-oxygenase and placental
prostaglandin synthesis lead to myometrial contractility and
premature parturition [2].
In vivo and vitro studies have established that both term and
preterm labor are associated with up-regulation of the Cox2
enzyme that synthesizes prostaglandins [3,4]. Indomethacin, a
non-selective cyclooxygenase (Cox) inhibitor has been used widely
to prevent preterm delivery; however concerns regarding fetal side
effects have limited its use [5]. Recently anecdotal data suggested
that Cox2 selective inhibitors may prevent preterm delivery [6].
Progesterone therapy has recently been recommended to
prevent preterm delivery in women at high risk women with a
previous history of preterm delivery [7] and in those with a short
cervix [8]. It is not known if women in whom inflammatory stimuli
promote the onset of labor could be treated effectively with
progesterone.
There have been no clinical trials of progesterone or Cox2
inhibitor therapy in pregnant women with subclinical infection.
We propose that the presence of subclinical infection/inflamma-
tion may suppress the therapeutic effect of progesterone and Cox2
inhibitors. Since it is unethical to conduct a prospective
experiment without antibiotic treatment of pregnant women with
subclinical infection, we developed a computer simulation of the
molecular events that lead to an increase in the PRA/PRB ratio to
labor levels in the myometrium, and tested the effect of
progesterone supplementation and Cox2 specific inhibitors on
labor associated changes in biochemical markers as the end-point.
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NF-kB Activation Leads to an Increase in the PRA/PRB
Ratio In Silico
We developed a dynamic computer simulation of the molecular
events in myometrium at labor. In order to simulate sub-acute and
full-blown infection we tested the model at 4 different levels of NF-
kB activation. Lowest level NF-kB activation was achieved by a
phospho-IkB kinase (IKK) concentration of 0.25 mM( ,80 fold
higher than baseline) and this level of NF-kB activation was
assumed to be similar to that seen during subclinical-infection. At
this level of NF-kB activation there was a limited Cox2 activation
(Cox2 mRNA concentration 0.085 mM) and PGE2 protein level
was low (0.35 mM=1.2 mg/ml). The highest level of NF-kB
activation was achieved by an IKK concentration of 1 mM. At
this level of NF-kB activation Cox2 mRNA concentration was
0.125 mM (1.5 fold increase above baseline) and PGE2 protein
concentration was 2.2 mM=7.7 mg/ml (,6 fold above baseline).
We observed that NF-kB activation led to an increase in PRA
and PRB mRNA and protein expression. At lowest level of NF-kB
activation PRA protein increased 14 fold above baseline (Figure 1A
and 1B); PRB mRNA and protein expression increased 4.2 fold
Figure 1. The effect of various levels of NF-kB activation on PRA mRNA and protein expression. We ran the simulation for 15000
seconds. We observed that in silico NF-kB activation increased the steady state levels of both PRA mRNA (1A) and protein levels (1B) above those seen
in the nonlabor state (0.0033 mM for PRA mRNA and 2.21E-5 mM for PRA protein).
doi:10.1371/journal.pone.0008502.g001
In Silico Model of Pregnancy
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PRA and PRB mRNA and protein curves shifted to the left and
the PRA/PRB ratio increased to labor levels (6.261.5) [9] earlier
(Figure 3). At the highest level of NF-kB activation the increase in
PRA/PRB ratio was highest (2.9 fold higher than the lowest-
nonlabor level of NF-kB activation (Figure 3).
Figure 2. The effect of various levels of NF-kB activation on PRB mRNA and protein expression. We ran the simulation for 15000 seconds.
We observed that in silico NF-kB activation increased both steady state PRB mRNA (2A) and protein levels (2B) above those seen in the nonlabor state
(0.0014 mM for PRB mRNA and 8.89E-6 mM for PRB protein).
doi:10.1371/journal.pone.0008502.g002
In Silico Model of Pregnancy
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NF-kB Induced PRA/PRB Increases
Progesterone treatment has recently been recommended for the
prevention of preterm delivery in women with a previous history of
preterm delivery and for those with short cervix [7,8].
We tested the effect of progesterone treatment on the NF-kB-
induced PRA/PRB increase. In order to do this we assumed that
the protective effect of progesterone would be mediated by PRB
[9,10], and the activity of PRB is determined by the level of tissue
PRB expression. Currently there are no data on the concentration
of myometrial progesterone receptor expression in vivo in pregnant
women receiving progesterone supplementation. In order to
simulate progesterone treatment we increased the PRB mRNA
concentration 2, 5 and 10 fold above the baseline
(0.04 mM=3.96 mg/ml) in the presence of subclinical infection
levels of NF-kB activation. We observed that in the presence of
subclinical infection the lower two concentrations of progesterone
treatment were not effective but at the highest concentration of
progesterone, the PRA/PRB ratio was suppressed to pre-
parturition levels (Figure 4).
Cox2 Inhibitors Do Not Prevent Infection Induced
Progesterone Withdrawal In Silico
Next we tested whether addition of a Cox2 specific inhibitor
would prevent the NF-kB-induced PRA/PRB increase. A
hypothetical Cox2 inhibitor with Ki (dissociation constant) of
Figure 3. The effect of various levels of NF-kB activation on PRA/PRB. We ran the simulation at various levels of NF-kB activation for 15000
seconds. We observed that in silico NF-kB activation increased the PRA/PRB ratio to labor levels (6.261.5).
doi:10.1371/journal.pone.0008502.g003
Figure 4. The effect of increased PRB on NF-kB induced PRA/PRB increases. We hypothesized that progesterone treatment effect will be
regulated by the level of PRB expression. In the simulation we increased the PRB expression 2, 5 and 10 fold above baseline and observed that only
the highest concentration of PRB prevented the PRA/PRB ratio increase to the levels seen at labor (6.2 mean).
doi:10.1371/journal.pone.0008502.g004
In Silico Model of Pregnancy
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0.25 mM and 0.5 mM to the model set at a low level of NF-kB
activation. We observed that only the highest concentration of
Cox2 inhibitor (0.5 mM) prevented the NF-kB-induced increase in
PRA/PRB ratio to labor levels (Figure 5).
Discussion
Here we used a systems biology approach to test whether the
presence of subclinical infection/inflammation would modulate
progesterone or Cox2 inhibitor effect on the generation of a PRA to
PRB ratio associated with labor. In order to do this we developed a
dynamiccomputersimulationofmyometriumatthemolecularlevel
using differential equations. We observed that only at the highest
concentrations do progesterone and Cox2 specific inhibitors
prevent the NF-kB induced PRA/PRB increase. In the case of
progesterone there have been recent clinical data that support this
observation [13]. In the case of Cox2 inhibition, high concentra-
tions of Cox2 inhibitor may have increased fetal toxicity [14].
System Biology seeks to use mathematical modeling to integrate
currently available genomic, proteomic, in vitro and in vivo data into
functional models of biological systems. An effective model of a
complex system has a number of potential benefits, notably it may
be possible to use the model to predict the behavior of the system
when disturbed by pathology or the response of the system to a
therapeutic.
The simulations are especially valuable to answer questions that
cannot be readily tested, such as new treatments of preterm
delivery. The regulation of human parturition is demonstrably
different in many ways from that in other mammals. In particular,
in most mammals parturition follows a rapid fall in circulating
maternal concentrations of progesterone while in the human
circulating progesterone levels show no signs of falling until after
removal of the placenta. The consequence of the inter-species
differences is that animal studies give only limited insight into the
mechanisms of human labor. Experimental studies are also
problematic in the setting of human labor for ethical reasons.
In this manuscript we have started to develop a model of the
molecular events occurring in the human myometrial cell as it
transitions at term from non-laboring to the laboring state. Data
was obtained from the literature on the perceived critical variables.
In this context the critical factors were considered to be the
concentrations of progesterone receptors and estrogen receptors
and associated factors. To generate the model a number of explicit
assumptions were made where clinical or in vitro data were
unavailable. These assumptions are described in the Methods
section.
The model was designed in a bottom-up fashion. Every change
to a molecular species, interaction between two or more species,
transportation of a species from one compartment to another,
transcription and translation is counted as a reaction. The model
includes 199 different molecules, 208 reactions, and 624 kinetic
parameters.
The model was designed such that activation of NF-kBl e dt o
an increase in PRA/PRB ratio to labor levels, reflecting the
observation that infection/inflammation is a well known risk
factor for preterm delivery. We have then explored how the
model responds to a potential tocolytic in the form of a Cox2
inhibitor or progesterone, in the presence of subclinical
infection/inflammation. We observed that neither a 10 fold
increase in progesterone receptor nor a 2 fold increase in Cox 2
inhibition were effective in preventing the PRA/PRB increase at
levels of NF-kB activation that might occur during subclinical
infection. These results parallel a recent double-blind, placebo
controlled human trial where treatment with a selective Cox2
inhibitor did not reduce the incidence of early preterm delivery
[14].
Here we describe the use of a computer model of pregnancy and
labor in the myometrium and show that progesterone and Cox2
inhibitor treatments may not be effective in women with
subclinical infection. Our results also suggest that a computer
simulation can be used as a novel discovery tool to develop
hypotheses and test mechanistic and therapeutic hypotheses before
moving into lengthy and costly clinical trials.
Figure 5. Effect of Cox2 inhibitor on the NF-kB induced PRA/PRB increase. We added a hypothetical Cox2 inhibitor to the system at
concentrations of 0.1, 0.25 and 0.5 mM. Only the highest concentration Cox2 inhibitor decreased the PRA/PRB ratio.
doi:10.1371/journal.pone.0008502.g005
In Silico Model of Pregnancy
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Building the Model
First we built a static diagram of the molecular interactions
during pregnancy based on Pubmed data (Figure 6). We then
created differential equations to express the dynamic interactions
between the molecules. The model included three compartments:
intracellular, extracellular and intranuclear. Rates of change of the
concentration of each molecule with time were modeled as
differential equations that were solved by the DOPRI5 method as
previously described [15]. The method of development is
illustrated with the following examples:
1. Example of an equation representing the irreversible transport
of estrogen receptor (ER) mRNA from the nucleus to the
cytoplasm:
d ERmRNACyt ½  =dt~Kf ERTR ERmRNAN ½  z
Kr PreER½PreER {Kf PreER ERmRNACyt ½  fg
In this equation ERmRNAN ½  represents nuclear estrogen
receptor mRNA concentration,
ERmRNACyt ½  represents the cytoplasmic estrogen receptor
mRNA concentration and PreER ½  represent the precursor of
functional estrogen receptor protein. The above transport reaction
has been modeled as a irreversible reaction with Kf ERTR
representing the rate of the forward reaction of its formation and
its utilization is represented as a reversible reaction with
Kf PreER representing the rate of its forward reaction and
Kr PreER the rate of its reverse reaction.
N Example of an equation representing a binding reaction: Here
the change in concentration of cytoplasmic ES ER1 Cyt with
respect to time would be:
dE SER1 Cyt ½  =dt~ Kf ERbd ESR1 HSP90 ½  ES ½  ðÞ { ð f
Kr ERbd HSP90 ½  ES ESR1 Cyt ½  ð ÞÞ Vcytgz
Kr ES ER Tr ES ER1 N ½  {Kf ES ER1 Cyt ½  ðÞ fg
N Binding of estrogen to ER with the release of hsp90 and E2-
ER complex.
This is modeled as a reversible reaction. The ligand estrogen
represented by ES binds to the estrogen receptor complexes with
HSP90 ½  ES ESR1 Cyt ½  in the cytosol. The binding of estrogen
to the receptor causes the release of the Hsp90 chaperone to form
the E2_ER complex; which is then translocated to the nucleus.
The model is ‘‘run’’ in a Cellworks Group internal computa-
tional engine that solves the differential equations and simulates
the dynamic model (please see Supplementary file S1 – JSIM
instructions and file S2 - MML file).
Model Assumptions
Progesterone regulation of parturition. During
pregnancy there is a continuous supply of progesterone, action
of which is controlled by tissue receptor levels [16]. Although
Figure 6. Basic schema of the in silico model. The molecular signaling cascades that connect the inflammatory and endocrine environment are
shown in a simplified manner in intracellular and intranuclear compartments. PRB-TC – PRB transcription complex; PRA-TC – PRA transcription
complex; ER n – ER in nucleus; PRB n – PRB in nucleus; PRA n – PRA in nucleus; NF-kB n – NF-kB in nucleus; FP – FP receptor of prostaglandin (PG)F2;
EP1 & EP2 – EP receptors of PGE2; PL – Phospholipid; AA – Arachidonic acid.
doi:10.1371/journal.pone.0008502.g006
In Silico Model of Pregnancy
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myometrium [16,17], the two major subtypes are PRA and
PRB; are encoded by a single gene and are produced
independently from separate promoters [18]. PRA is a truncated
form of PRB that lacks the first 164 N-terminal amino acids [19].
The PRA promoter has AP-1 binding sites and AP-1 is activated
by MAP Kinases which in turn are activated by protein kinase C
(PKC); the PRB promoter has a CAAT binding site [20]. In the
model we assumed that PRB expression is due to protein kinase A
(PKA) induced CAAT/enhancer-binding protein beta (C/EBP)
expression; which then binds to the CAAT site of the PRB
promoter (Figure 6).
In most human cell types and in the majority of promoter
systems examined to date, PRB is the principal ligand-dependent
transcriptional activator of progesterone-responsive genes, where-
as PRA is a ligand-activated repressor of the transcriptional
activity mediated by PRB [19,21,22]. In vitro studies indicate that
PRA blocks progesterone action by inhibiting the transcriptional
activity of PRB [20] and consequently suppresses progesterone
responsiveness.
Several studies have indicated that in humans parturition is
preceded by an increase in the expression of the progesterone
dominant negative PRA relative to PRB; which leads to a
functional progesterone withdrawal [9,22–25]. In the model the
PRA/PRB ratio seen in the myometrium of laboring pregnant
women (6.261.5) [9] was used as the threshold for parturition.
The nonlabor progesterone receptor (PR) B mRNA concentration
was set at 0.04 mM and PRA mRNA concentration was set at
0.04 mM based on previous data [9].
Estrogen Regulation of Parturition
Estrogen is classically considered to be pro-labor. Since there is
abundance of estrogen during the pregnancy, the activity of
estrogen is thought to be regulated by the tissue estrogen receptor
levels. ER alpha is the main receptor in the uterus, expression of
which changes during the parturition [9]. We used ER alpha in all
simulations and represented as ER. The pre-labor ER mRNA
concentration was 0.01 mM in the system.
During pregnancy the transcriptional activity of PRB is higher
than that of ER, and PRA transcription increases in association
with the onset of labor [22,24,26]. ER mediated transcription is
inhibited by both PRB and PRA, with the PRB inhibition being
more significant [27]. Increases in the PRA to PRB ratio leads to
increased expression of the estrogen receptor (ER) alpha and
subsequent expression of contraction associated proteins such as
connexin 43, oxytocin receptor and cyclo-oxygenase 2 which lead
to the development of the synchronous powerful contractions of
labor.
Coactivators regulate the estrogen and progesterone
action. Unliganded PR and ER are kept in the cytoplasm by
chaperone proteins (such as Hsp70, Hsp90 and immunophilins),
and coactivator molecules, such as CBP, p300 or SRC-1 (steroid
receptor coactivator-1) mediate the transcriptional activity of ER
and PR by means of their histone acetyl transferase functions. We
included the chaperone proteins Hsp70, Hsp90 and
immunophilins, and coactivator molecules CBP, p300 and SRC-
1 and their dynamic interactions with PR and ER in our model
(Figure 6). The model incorporates functional progesterone
withdrawal by both altering progesterone receptor (PR) isoform
abundance [28] and by diminishing the PRB interaction with
progesterone response elements and coregulators due to
competition with PRA for these regulators [28,29].
NF-kB is activated during labor. NF-kB is known to play a
role in parturition and is activated in amnion cells and myometrial
homogenates during parturition [30]. The active NF-kB levels are
higher during labor than nonlabor [3,31]. Currently there are no
data on the concentration of phospho-IKK or activated NF-kBi n
the laboring myometrium in vivo. However it has been previously
suggested that a small concentration of active NF-kB will be
present in all living cells [32]. To show this, we assumed phospho-
IKK concentration to be 0.003 mM at baseline; which leads to a
steady state NF-kB concentration of 0.0125 mM, compatible with
the literature [32]. We assumed phospho-IKK concentration to be
0.5 mM and NF-kB level to be 0.5 mM (,160 fold higher than
baseline) during parturition. This level of NF-kB activation leads
to an increase in Cox2 mRNA levels from 0.00054 mM at pre-
labor to 0.28 mM at labor, and a 15 fold increase in PRA
expression and a 4.2 fold increase in PRB expression with labor.
These data corroborate the Cox2 activation observed in vivo in the
laboring women [9].
Model of infection. NF-kBi st h em a i nt r a n s c r i p t i o nf a c t o r
responsible for infection induced inflammatory response [33]. In the
inactive state NF-kBi sf o u n di nt h ec y t o p l a s mb o u n dt oI k B a.
Infection leads to the activation of a cascade of molecules that lead to
the activation of IkB kinase (IKK) which then phosphorylates IkBa;
phosphorylated IkBa isubiquinated and degraded [32], leaving active
NF-kBf r e et om o v ei n t ot h en u c l e u st oi n i t i a t ei n f l a m m a t o r yg e n e
expression including the expression of Cox2 [33].
Currently there are no data on infection induced NF-kB
activation in the human myometrium. However experiments with
human uterine myometrial cells suggest that IL-1 induced NF-kB
activation leads to proinflammatory cytokine expression in these
cells [34,35]. Animal models of pregnancy show that intrauterine
infection leads to myometrial inflammatory cytokine expression;
which suggests NF-kB activation [36,37].
We assumed that infection will lead to IKK phosphorylation
and NF-kB activation in the human pregnant myometrium. In the
model, the phospho-IKK level was manipulated by the user to
increase the active NF-kB levels.
NF-kB regulates the PRA/PRB ratio. NF-kB and the
progesterone receptor mutually regulate the activity of each other
[38]. PRB binds and inhibits NF-kB mediated transcriptional
activation in HeLa cell transfection experiments [38]. NF-kB
inhibits PRB-transcription complex formation and PRB-induced
PRB transcription in HeLa, COS-1 and T47D breast cancer cell
lines [39].
Currently there are no data on the effect of NF-kB activation on
myometrial PRA, PRB or ER alpha expression. However it is well
established that intrauterine infection is associated with preterm
parturition and NF-kB is known to be activated during parturition.
Therefore in the model we assumed that NF-kB activation leads to
an increase in PRA/PRB ratio. This was achieved by NF-kB
induction of PRB expression through protein kinase A and
CCAAT/enhancer-binding protein (CEBP) and PRA expression
indirectly through MAP kinase and AP-1 activation (Figure 6).
Cox2 and labor. Cox2 is activated in the myometrium of
laboring women [9]. Cox2 then leads to prostaglandin (PG)
expression; cervical PGE2 and PGF2 play the central role in
cervical remodeling, effacement, uterine contractions and labor
[40], and agonists of both prostaglandins are used in the clinic to
induce labor.
Based on previous data we assumed that PGF2 induce protein
kinase C (PKC) activation through the FP receptor [41]; PKC
then activates MAP kinases to regulate AP-1 expression in the
myometrial cells [42]. In our model Cox2 induces PGE2 and
PGF2 expression which then leads to PKC activation (Figure 6).
PKC then activates MAP kinase phosphorylation, AP-1 activation
and increases PRA expression (Figure 6).
In Silico Model of Pregnancy
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